Anna Sanecka-Duin, PhD

Dr. Anna Sanecka-Duin has a diverse work experience in the field of research and immunology. Anna is currently employed at Ardigen, where they hold the position of Lead Scientist starting from December 2021. Prior to this role, they worked as a Senior Scientist at the same company from December 2018 to November 2021.

Before joining Ardigen, Dr. Sanecka-Duin served as a Postdoctoral Researcher at the Department of Immunology, Jagiellonian University. Anna held this position from February 2016 to November 2018.

In 2015, Dr. Sanecka-Duin had a short-term role as a Postdoctoral Researcher at The Francis Crick Institute. During this time, they focused on characterizing Toxoplasma gondii specific CD8 T cells in the brains of chronically infected mice and investigating the impact of affinity in MHCI-TCR interaction on the fate of CD8 T cells.

From October 2011 to March 2015, Dr. Sanecka-Duin worked as a Postdoctoral Researcher at The National Institute for Medical Research, Medical Research Council.

In their earlier career, Dr. Sanecka-Duin served as a PhD student at the Department of Tumor Immunology, NCMLS, Radboud University Nijmegen Medical Centre from August 2006 to November 2010.

Anna also gained experience as a trainee at Cellerix, Madrid, Spain in 2005 and at the Max Planck Institute of Biochemistry, Martinsried, Germany in 2004.

Overall, Dr. Anna Sanecka-Duin has a strong background in research, with a focus on immunology, and has held various positions in renowned institutes and organizations throughout their career.

Anna Sanecka-Duin, PhD, received their Master's degree in Biotechnology from Jagiellonian University, where they studied from 2000 to 2005. Anna then pursued their doctoral studies in Life Sciences at Radboud University, completing their PhD from 2006 to 2012.